Northern Trust Corp Syros Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.69 - $1.21 $269,393 - $472,414
-390,425 Reduced 80.16%
96,658 $93,000
Q1 2022

May 13, 2022
SELL
$1.02 - $3.8 $38,552 - $143,628
-37,797 Reduced 7.2%
487,083 $579,000
Q4 2021

Feb 08, 2022
BUY
$3.26 - $4.66 $655 - $936
201 Added 0.04%
524,880 $1.71 Million
Q3 2021

Nov 15, 2021
SELL
$4.08 - $5.66 $121,351 - $168,345
-29,743 Reduced 5.36%
524,679 $2.35 Million
Q2 2021

Aug 13, 2021
BUY
$5.01 - $7.48 $172,930 - $258,187
34,517 Added 6.64%
554,422 $3.02 Million
Q1 2021

May 12, 2021
BUY
$7.19 - $14.95 $489,761 - $1.02 Million
68,117 Added 15.08%
519,905 $3.89 Million
Q4 2020

Feb 11, 2021
SELL
$6.66 - $14.66 $66,913 - $147,289
-10,047 Reduced 2.18%
451,788 $4.9 Million
Q3 2020

Nov 16, 2020
SELL
$8.69 - $14.47 $261,916 - $436,125
-30,140 Reduced 6.13%
461,835 $4.08 Million
Q2 2020

Aug 14, 2020
BUY
$5.21 - $11.03 $440,943 - $933,513
84,634 Added 20.78%
491,975 $5.25 Million
Q1 2020

May 14, 2020
BUY
$4.46 - $9.2 $26,046 - $53,727
5,840 Added 1.45%
407,341 $2.42 Million
Q4 2019

Feb 14, 2020
SELL
$4.52 - $10.1 $114,581 - $256,035
-25,350 Reduced 5.94%
401,501 $2.77 Million
Q3 2019

Nov 13, 2019
BUY
$7.14 - $11.65 $679,763 - $1.11 Million
95,205 Added 28.71%
426,851 $4.43 Million
Q2 2019

Aug 13, 2019
BUY
$5.5 - $9.75 $138,556 - $245,622
25,192 Added 8.22%
331,646 $3.07 Million
Q1 2019

May 13, 2019
BUY
$5.51 - $9.59 $1,581 - $2,752
287 Added 0.09%
306,454 $2.8 Million
Q4 2018

Feb 12, 2019
BUY
$5.55 - $11.34 $12,093 - $24,709
2,179 Added 0.72%
306,167 $1.71 Million
Q3 2018

Nov 14, 2018
BUY
$9.74 - $12.92 $276,129 - $366,282
28,350 Added 10.29%
303,988 $3.62 Million
Q2 2018

Sep 18, 2018
SELL
$10.16 - $13.65 $19,872 - $26,699
-1,956 Reduced 0.7%
275,638 $2.81 Million
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $980,480 - $1.32 Million
96,504 Added 53.29%
277,594 $2.83 Million
Q1 2018

May 09, 2018
BUY
$9.47 - $12.98 $444,398 - $609,112
46,927 Added 34.98%
181,090 $2.35 Million
Q4 2017

Feb 14, 2018
SELL
$8.45 - $17.48 $17,753 - $36,725
-2,101 Reduced 1.54%
134,163 $1.31 Million
Q3 2017

Nov 13, 2017
BUY
$13.52 - $23.75 $1.84 Million - $3.24 Million
136,264
136,264 $2.01 Million

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email